Industry Insights: Where Does Immuno-Oncology Fit in a Value-Based Care Delivery Model?

Bruce Feinberg, DO

The American Society of Clinical Oncology (ASCO) has named cancer immunotherapy the “Advance of the Year” for 2016.

Real-world Insights

Members Login

Become a member today